Jessica Schmitt

ORCID: 0000-0003-0733-2000
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Diabetes Management and Research
  • Diabetes and associated disorders
  • Pancreatic function and diabetes
  • Effects of Environmental Stressors on Livestock
  • Ruminant Nutrition and Digestive Physiology
  • Mobile Health and mHealth Applications
  • Sexual Differentiation and Disorders
  • Ovarian function and disorders
  • Animal health and immunology
  • Reproductive Physiology in Livestock
  • Optimism, Hope, and Well-being
  • Obesity and Health Practices
  • Down syndrome and intellectual disability research
  • COVID-19 Clinical Research Studies
  • Connective tissue disorders research
  • Patient-Provider Communication in Healthcare
  • Bone health and osteoporosis research
  • Diabetes Treatment and Management
  • Animal Diversity and Health Studies
  • Adolescent and Pediatric Healthcare
  • High Altitude and Hypoxia
  • Diabetes Management and Education
  • Muscle metabolism and nutrition
  • Family and Disability Support Research
  • Medication Adherence and Compliance

University of Alabama at Birmingham
2019-2025

University of Alabama at Birmingham Hospital
2022

University Hospital of Zurich
2011

Despite documented benefits of diabetes technology in managing type 1 diabetes, inequities persist the use these devices. Provider bias may be a driver inequities, but evidence is limited. Therefore, we aimed to examine role race/ethnicity and insurance-mediated provider implicit recommending technology.

10.1089/dia.2022.0042 article EN cc-by-nc Diabetes Technology & Therapeutics 2022-05-23

There is concern that the growing incidence of pediatric type 2 diabetes (T2D) may have been further exacerbated by COVID-19 pandemic.To examine whether trends in new-onset T2D-inclusive patients requiring hospitalization and managed as outpatients-were impacted during pandemic, to compare patient characteristics prior COVID-19.A retrospective single-center medical record review was conducted a hospital which cares for 90% Alabama's T2D patients. Patients with referred from March 2017 2021...

10.1210/clinem/dgac209 article EN The Journal of Clinical Endocrinology & Metabolism 2022-04-04

Adolescence can be defined as the period during which all individuals move from childhood to adulthood, including in healthcare system, creating a need for transition process. Children's of Alabama provides four education sessions clinic visits adolescents with type 1 diabetes (T1D). We aimed assess baseline patient data and perspectives our current process guide efforts improve this used mixed methods design comprised quantitative analysis T1D qualitative provide perspectives. queried...

10.1016/j.hctj.2025.100097 article EN cc-by-nc-nd Health Care Transitions 2025-01-01

Incidence of type 2 diabetes mellitus (T2DM) and obesity is increasing in children. We aimed to observe the metabolic health effects glucagon-like peptide 1 (GLP-1) receptor agonists paediatric patients with T2DM a real-world setting. A retrospective chart review aged 0 18 years who were started on GLP-1 agonist between August 2019 2023 followed for up 24 months was included this study. 321 analysis. After 12 treatment agonist, haemoglobin A1c (HbA1c) reduced by -1.04% ± 2.3% (p < 0.001). At...

10.1002/edm2.70053 article EN PubMed 2025-05-01

Background: Continuous glucose monitors (CGMs) are a tool that can reduce the burden of self-monitoring values in children and adults with type 1 diabetes (T1D), associated improved glycemic control, reduced fear hypoglycemia. Unfortunately, disparities access to CGM exist rates Alabama 2019 were below national averages. We aimed increase by race, insurance status, high-risk status. Methods: Stakeholder input identified barriers defined existing process. Process changes implemented studied...

10.1089/dia.2021.0511 article EN Diabetes Technology & Therapeutics 2022-02-14

This study sought to identify barriers and facilitators successful smart insulin pen (SIP) use gauge prescribing practices integration into clinical practice by assessing provider care team perspectives at participating endocrinology clinics within the T1D Exchange Quality Improvement Collaborative. The identified provider-related, patient-related, clinic- operational-level varied based on clinic knowledge, capacity, resources. High-impact included insurance coverage processes; high-impact...

10.2337/cd22-0068 article EN Clinical Diabetes 2022-09-15

Abstract Introduction Prevalence of diabetic ketoacidosis (DKA) complicated by severe hyperglycaemia and hyperosmolality its outcomes in youth with type 2 diabetes (T2DM) are not well‐described. Our aim is to determine the frequency clinical isolated DKA, DKA (DKA + SHG) HH) T2DM admitted for acute hyperglycaemic crisis. Methods Through retrospective medical record review, patients were identified categorized into SHG glucose ≥33.3 mmol/L) HH mmol/L osmolality ≥320 mmol/kg). Results...

10.1002/edm2.160 article EN cc-by Endocrinology Diabetes & Metabolism 2020-06-15

&lt;b&gt;&lt;i&gt;Introduction:&lt;/i&gt;&lt;/b&gt; Insulin degludec (IDeg) is the longest-acting basal insulin available. Whether IDeg compared to shorter-acting insulins like glargine U100 (IGlarU100) reduces rate of diabetic ketoacidosis (DKA) in adolescents with type 1 diabetes unknown. &lt;b&gt;&lt;i&gt;Objective:&lt;/i&gt;&lt;/b&gt; We hypothesized that would have lower DKA rates and mean hemoglobin A1c (HbA1c) when using as IGlarU100. &lt;b&gt;&lt;i&gt;Methods:&lt;/i&gt;&lt;/b&gt; To...

10.1159/000504707 article EN Hormone Research in Paediatrics 2019-01-01

Brain MRIs are considered essential in the evaluation of children diagnosed with growth hormone deficiency (GHD), but there is uncertainty about appropriate cut-off for diagnosis GHD and little data yield significant abnormal findings patients peak (GH) 7-10 ng/mL. We aimed to assess frequency pathogenic associated risk factors relation GH concentrations.In this retrospective multicenter study, charts who subsequently had a brain MRI were reviewed. categorized as normal, incidental,...

10.1515/jpem-2020-0579 article EN Journal of Pediatric Endocrinology and Metabolism 2021-02-22

Prediabetes (PD) is becoming more common, and management complicated by high rates of loss to follow-up. We evaluated variables associated with lost follow-up status for pediatric patients PD referred endocrinology evaluation management.

10.1210/jendso/bvae157 article EN cc-by Journal of the Endocrine Society 2024-08-27

Background & aims: Human iron metabolism is closely regulated by erythropoesis, oxygen homeostasis and intestinal absorption. The aim of this study was to characterize for the first time adaptation transport hypoxia under high altitude conditions in man at levels (i) uptake (ii) changes systemic hemoglobin one comprehensive overview.

10.1055/s-0031-1285221 article EN Zeitschrift für Gastroenterologie 2011-08-01

Background. Racial disparities are well described in glycemic outcomes youth with Type 1 diabetes mellites (T1D). Hemoglobin A1c (HbA1c) has some limitations comparing glycemia across patient groups as there individual variations mean glucose and HbA1c. Objective. This study aimed to compare metrics obtained from (Dexcom G6) continuous monitor (CGM) device HbA1c levels controlling for race, age, duration of diabetes, insurance status, insulin pump use control. Subjects Methods. Data analyzed...

10.1155/2023/6646582 article EN Pediatric Diabetes 2023-10-25

10.1177/2374373519862929 article EN cc-by-nc Journal of Patient Experience 2019-07-10
Coming Soon ...